Autor:	Rachel Gordon, Vicki L. Sato
Kategorie:	BUSINESS & ECONOMICS / General
Popis:	Dr. John Mendlein, CEO of Adnexus Therapeutics Inc., (Adnexus), a private biotechnology company, must decide whether to pursue acquisition talks with Bristol-Myers Squibb (BMS) after a successful six month collaboration or continue with Adnexus'planned IPO.
Databáze:	eBook Index
Externí odkaz:	Zobrazit plný text záznamu